Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry
|
|
- Lee Dawson
- 5 years ago
- Views:
Transcription
1 University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate Professor of Vascular Surgery, University of Milan Head, Unit of Vascular Surgery II Director, Thoracic Aortic Research Center IRCCS Policlinico San Donato
2 Disclosures Grants: Italian National Research Council (CNR), CARIPLO Foundation, San Donato Foundation, Gore WL, Medtronic inc. Consultant and Speaker: Gore WL, Medtronic inc.
3 Complicated Type B Dissection: Guidelines ESC 2014
4 Complicated Acute B Dissection TEVAR: 9-11 % mortality Open repair: % mortality Circulation 2005 JACC Int. 2008
5 Aortic Remodeling after TEVAR for Type B Aortic Dissection Aortic Remodeling in Acute Uncomplicated Type B Dissections Aortic Remodeling in Complicated Type B Dissections Aortic Remodeling in Chronic Type B Dissections Baseline After 2 years
6 Aortic Remodeling in Acute Uncomplicated Type B Dissections Acute uncomplicated type B dissections randomized: BMT vs. TEVAR Incomplete false lumen thrombosis 13 (43%) TEVAR vs. 30 (97%) BMT (p <.001)
7 Aortic Remodeling in Acute Uncomplicated Type B Dissections Acute uncomplicated type B dissections randomized: BMT vs. TEVAR TL increase TEVAR vs. no change BMT
8 Aortic Remodeling in Acute Uncomplicated Type B Dissections Acute uncomplicated type B dissections randomized: BMT vs. TEVAR FL reduction in the TEVAR group vs. FL increase in BMT group
9 Aortic Remodeling in Chronic Type B Dissection Chronic type B aortic dissections randomized to TEVAR or OMT Benefit of TEVAR for all end points at 5 years All-cause mortality (0% versus 16.9%; P=0.0003) Aorta-specific mortality (0% versus 16.9%; P=0.0005) Progression of dissection (4.1% versus 28.1%; P=0.004) Baseline and 5y FU
10 Aortic Remodeling in Chronic Type B Dissection Chronic type B aortic dissections randomized to TEVAR or OMT Benefit of TEVAR for all end points at 5 years All-cause mortality (0% versus 16.9%; P=0.0003) Aorta-specific mortality (0% versus 16.9%; P=0.0005) Progression of dissection (4.1% versus 28.1%; P=0.004) At 5 years after TEVAR: 90.6% exhibited complete FL thrombosis 79.2%morphological evidence of remodeling Baseline and 5y FU
11 Aortic Remodeling in Chronic Type B Dissection Chronic type B dissection patients (n=51) treated with TEVAR At 2-year FU : Overall aortic diameter decrease from 6.2cm to 5.0 cm (P =.0002) 87% of patients showed complete reverse remodeling of the thoracic aorta Baseline 2y FU
12 Aortic Remodeling in Type B Dissection Acute (n=50), subacute (n=24) and chronic dissections (n=26) treated with TEVAR True lumen increase after TEVAR in all groups without differences
13 Aortic Remodeling in Acute and Subacute Type B Dissection Acute (n=50), subacute (n=24) and chronic dissections (n=26) treated with TEVAR FL decrease most prominent in acute and subacute
14 Aortic Remodeling in Chronic Type B Dissection Acute (n=50), subacute (n=24) and chronic dissections (n=26) treated with TEVAR FL decrease most prominent in acute and subacute FL decrease less in chronic dissection
15 Aortic Remodeling in Chronic Type B Dissection Acute (n=50), subacute (n=24) and chronic dissections (n=26) treated with TEVAR FL thrombosis percentage increased after TEVAR
16 Aortic Remodeling in Chronic Type B Dissection Acute (n=50), subacute (n=24) and chronic dissections (n=26) treated with TEVAR FL thrombosis percentage between diaphragm and coeliac axis was significantly lower in chronic dissections compared to acute and subacute dissections (p=0.035)
17 Volumetric Changes of Aortic Remodeling in Type B Dissections Analysis of CT-scans after TEVAR for uncomplicated chronic dissection (A) and chronic dissection with aneurysm (B) Stent graft proximally increasing 4.4%, 10.1%, and 14.2%, respectively, at 6, 12, and 36 months Stent graft distally increasing 42.6%, 67.2%, and 72.3%, respectively, at 6, 12, and 36 months Proximal stent Distal stent
18 Volumetric Changes of Aortic Remodeling in Type B Dissections Analysis of CT-scans after TEVAR for uncomplicated chronic dissection (A) and chronic dissection with aneurysm (B) Stent graft proximally increasing 4.4%, 10.1%, and 14.2%, respectively, at 6, 12, and 36 months Stent graft distally increasing 42.6%, 67.2%, and 72.3%, respectively, at 6, 12, and 36 months Proximal stent Distal stent Aortic remodeling is a continuous process
19 Volumetric Changes of Aortic Remodeling in Type B Dissections Analysis of CT-scans after TEVAR for uncomplicated chronic dissection (A) and chronic dissection with aneurysm (B) True lumen volume increase True lumen volume Aortic remodeling is a continuous process
20 Volumetric Changes of Aortic Remodeling in Type B Dissections Analysis of CT-scans after TEVAR for uncomplicated chronic dissection (A) and chronic dissection with aneurysm (B) False lumen volume decrease False lumen volume Aortic remodeling is a continuous process
21 Volumetric Changes of Aortic Remodeling in Type B Dissections Analysis of CT-scans after TEVAR for uncomplicated chronic dissection (A) and chronic dissection with aneurysm (B) FL thrombus volume decrease with shrinkage but FL thrombus percentage increase FL thrombus volume and percentage Aortic remodeling is a continuous process
22 Predictors of FL thrombosis after TEVAR
23 Volumetric Changes after TEVAR Thoracic TL volume Thoracic FL volume
24 Overview
25 Overview Commercial aortic endovascular products in global markets (US, EU, Australia, New Zealand, and Brazil) 5000 patients at up to 300 sites worldwide Observational (on-label and off-label use) 10 yrs Follow Up
26 GREAT Overview Outcomes Evaluation (EVAR and TEVAR) GRT Demographics, Medical History, Case Planning, Treatment Post-Treatment follow-up through 10 years including any Serious Adverse Events Gore Excluder featuring C3 Delivery System GRT Primary Objectives Evaluate procedural outcomes, to include: Estimation of the number of aortic extenders required per case Qualitative assessment of the repositioning capabilities of the device Qualitative assessments of device deployment accuracy
27 GREAT Data Quality Database design: Data points must meet data standard conformity Critical data points identified System queries generated In-house data monitoring: Independent reviewers Adverse Event Reviews Manual queries generated Site monitoring: For cause monitoring & site support Monitoring plan revised based on observations and need
28 GREAT Data Quality > 3500 patients enrolled
29 Aortic Pathologies Treated Abdominal aortic aneurysm 71% Common iliac aneurysm 10% Descending Thoracic aortic aneurysm 7% Type B complicated aortic dissection 3% Type B uncomplicated aortic dissection 2% Penetrating aortic ulcer 2% Abdominal aortic aneurysm rupture 3% Thoracoabdominal aortic aneurysm 2% Internal iliac aneurysm 2% < 2% Traumatic transection Pseudoaneurysm Aortic arch aneurysm Descending Thoracic aneurysm rupture Intramural hematoma Thoracoabdominal aneurysm rupture Type A complicated dissection Ascending Thoracic aneurysm Aortic arch aneurysm rupture Aortic coarctation Aorto-bronchial fistula Ascending Thoracic aneurysm rupture Descending aortic dissection rupture Type A uncomplicated dissection
30 The Gore GREAT Registry A real life data collection Re-Coarctation with dissection Type A Diss with Arch Tear FET Ao-Pulm. Fistulae
31 Type B Dissection Classification Acute, complicated (n=67) is defined as time from symptom onset to diagnosis 14 days with site reported complicated. Acute, uncomplicated (n=44) is defined as time from symptom onset to diagnosis 14 days with site reported uncomplicated. Chronic (n=67) is site reported time from symptom onset to diagnosis is >14 days.
32 Demographics Type B Dissections All N=177 Acute, Complicated N=67 Acute, Uncomplicated N=44 Chronic N=67 Male (%) 84% 79% 82% 90% Female (%) 16% 21% 18% 10% White/Caucasian (%) 67% 67% 71% 64% Age ys Mean (std dev) 62(12) 61(12) 62(12) 62(11)
33 Treatment data Type B Dissection sub-categories All N=177 Acute, Complicated N=67 Acute, Uncomplicated N=44 Chronic N=67 Procedure Survival 100.0% 100.0% 100.0% 100.0% Hospital Stay (days) Median
34 Treatment data Type B Dissection sub-categories All N=177 Acute, Complicated N=67 Acute, Uncomplicated N=44 Chronic N=67 Access Method Percutaneous 41% 39% 46% 42% Cut-down 70% 66% 60% 81% Surgical Conduit 3% 3% 7% 2% Access Site Femoral Artery 98% 99% 96% 100% Iliac Artery 2% 2% 5% 2% Infrarenal Aorta Brachial 5% 9% 5% 2% Other 5% 3% 7% 5%
35 Treatment by landing zone All Type B Dissections 4% 51% 4% 31% 10%
36 Treatment data Type B Dissection sub-categories All N=177 Acute, Complicated N=67 Acute, Uncomplicated N=44 Chronic N=67 Thoracic Landing N=154 N=58 N=35 N=62 Zone Z0 4% 2% 3% 7% Z1 5% 3% 3% 7% Z2 51% 52% 34% 60% Z3 31% 35% 46% 18% Z4 10% 9% 14% 10% Aortic Branch Vessel Procedure 38% 42% 23% 45%
37 Treatment data Type B Dissection sub-categories All N=177 Acute, Complicated N=67 Acute, Uncomplicated N=44 Chronic N=67 Thoracic Landing N=154 N=58 N=35 N=62 Zone Z0 4% 2% 3% 7% Z1 5% 3% 3% 7% Z2 51% 52% 34% 60% Z3 31% 35% 46% 18% Z4 10% 9% 14% 10% Aortic Branch Vessel Procedure 38% 42% 23% 45%
38 Aortic Branch Vessel Data Type B Dissection sub-categories
39 Aortic Branch Vessel Data Type B Dissection sub-categories
40 Aortic Branch Vessel Data Type B Dissection sub-categories
41 Follow up Type B Dissection Follow Up Time (Days) All Type B dissections n 150 Median 129 Range (0,841) There are no differences in follow up among the sub categories and both enrollment and follow up continue. Note: Follow-up time is defined as the time from initial procedure to the last known contact post discharge from initial procedure (however, deaths or withdrawals are counted as follow-up which can occur at any time point in the study).
42 30-Day Outcomes Type B dissection sub-categories All N=177 Acute, Complicated N=67 Acute, Uncompl N=44 Chronic N=67 Subjects With Any Event: 6% 5% 9% 4% Mortality Stroke/TIA Paraplegia/Paraparesis/ Spinal Cord Ischemia 1 Device-related Reinterventions Only those considered Serious Adverse Events 2 Device related reinterventions include any invasive or minimally invasive measure related to a deficiency of the device(s) implanted into the aorta performed at any time following the initial procedure.
43 Outcomes Over Time Type B dissection Subjects With Any Follow- Up and/or Event 1 Procedure 1 Month 6 Months 1 Year Total Mortality 1³ % Stroke/TIA % Paraplegia/Paraparesis/ Spinal Cord Ischemia % 1 Subjects are counted in the denominator if either had any reported date of contact ³ start of window and/or reported event in the window; all subjects with initial procedure date are counted in Procedure and Total windows. 2 Only those considered serious adverse events. ³ The one death occurred post procedure but on POD 0.
44 1 Subjects are counted in the denominator if either had any reported date of contact ³ start of window and/or reported event in the window; all subjects with initial procedure date are counted in Procedure and Total windows. 2 All reinterventions include any invasive or minimally invasive measure related to the initial aortic procedure performed at any time following the initial procedure; device related reinterventions include any invasive or minimally invasive measure related to a deficiency of the device(s) implanted into the aorta performed at any time following the initial procedure. Outcomes Over Time Type B dissection Subjects With Any Follow- Up and/or Event 1 Procedure 1 Month 6 Months 1 Year Total All Reinterventions 2 1% 4% 9% 2% 9% Conversion to Open Repair and/or Explant Additional Graft Other Procedure/Surgery Device Related Reinterventions
45 Serious Device Events over time Type B Dissection Total Procedure 1 Month 6 Months 1 Year Serious Endoleak 1 0 6% 8% 8% 7% Type IA Type IB Type II Type III Type IV Migration Fracture Compression Any type, including unspecified endoleaks 2 Does not include 'Device placement at incorrect location' or similar coded MedDRA term.
46 Conclusions
47 Conclusions Overall, Gore C-TAG performs nicely in TEVAR treatment of Type B dissection
48 Conclusions Overall, Gore C-TAG performs nicely in TEVAR treatment of Type B dissection Gore C-TAG promotes Aortic Remodeling in Type B dissection. In these pts, better results have been showed in the acute / subacute phases. 2 mts after dissection 3 mts after TEVAR 1 yr after TEVAR
49 Conclusions Overall, Gore C-TAG performs nicely in TEVAR treatment of Type B dissection Gore C-TAG promotes Aortic Remodeling in Type B dissection. In these pts, better results have been showed in the acute / subacute phases. The GORE GREAT Registry is a great opportunity to report both on common and uncommon aortic deseases.
50 University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate Professor of Vascular Surgery, University of Milan Head, Unit of Vascular Surgery II Director, Thoracic Aortic Research Center IRCCS Policlinico San Donato
Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan
The Gore GREAT Registry: Update about a real life data collection Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan Disclosures
More informationRole of Gender in TEVAR and EVAR results from the GREAT registry
Role of Gender in TEVAR and EVAR results from the GREAT registry Mauro Gargiulo Vascular Surgery University of Bologna - DIMES Policlinico S.Orsola-Malpighi Bologna, Italy mauro.gargiulo2@unibo.it Disclosure
More informationLa sindrome aortica acuta oggi
University of Milan Thoracic Aortic Research Center La sindrome aortica acuta oggi Santi Trimarchi, MD, PhD Professore Associato di Chirurgia Vascolare, Università degli Studi di Milano Direttore, Divisione
More informationAbdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
More informationIntroducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System K. Oikonomou Department of Vascular Surgery Regensburg University Disclosures W.L. Gore & Associates Sponsored Presentation
More informationThe Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations Joseph V. Lombardi, MD Professor & Chief, Division of Vascular & Endovascular Surgery Department of Surgery,
More informationUC SF Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial. Acute Type B Dissection. Outline. Disclosures.
Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial None Disclosures Jade S. Hiramoto, MD, MAS April 4, 2014 Outline Background Current treatment Results from INSTEAD trial Results
More informationThoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure
Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel, MD I
More informationGoing the distance: Conformable Gore TAG device demonstrates durable outcomes over the long. D.Böckler University Hospital Heidelberg, Germany
Going the distance: Conformable Gore TAG device demonstrates durable outcomes over the long D.Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following
More informationCombined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR William J. Quinones-Baldrich MD Professor of Surgery Director UCLA Aortic Center UCLA Medical Center Los Angeles,
More informationNo Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair
No Disclosure The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair Toru Kuratani Department of Cardiovascular Surgery Osaka University Graduate School of Medicine,
More informationUC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery?
UC SF Management of Acute Dissections: Is There Still a Role for Open Surgery? Darren B. Schneider, M.D. Assistant Professor of Surgery and Radiology Division of Vascular Surgery University of California
More informationGORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 2018 Abstract. Section I GORE TAG Device Clinical experience. Section II Conformable
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 08 Abstract This annual clinical update provides a review of the ongoing experience with the GORE TAG Thoracic Endoprosthesis There have
More informationClinical Trials of Acute and Chronic Dissections. Gregory Landry MD
Clinical Trials of Acute and Chronic Dissections Gregory Landry MD No disclosures Acute vs chronic dissection: Definitions 1950s: Acute < 2 weeks, Chronic > 2 weeks 2013: European Interdisciplinary Consensus
More informationGlobal Evidence for the Treatment of Type B Aortic Dissection
Global Evidence for the Treatment of Type B Aortic Dissection Ross Milner, MD Professor of Surgery Director, Center for Aortic Diseases September 17, 2016 Disclosures Consultant Cook, Endospan, Medtronic,
More informationIs there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands
Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands Disclosures: - Consultant Philips Health Care - Best Doctors Overview
More informationEVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury. Conflict of Interest. Hypotensive shock 5/5/2014. none
EVAR and TEVAR: Extending Their Use for Rupture and Traumatic Injury Bruce H. Gray, DO MSVM FSCAI Professor of Surgery/Vascular Medicine USC SOM-Greenville Greenville, South Carolina none Conflict of Interest
More informationRETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery
RETROGRADE BRANCH Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery FACULTY DISCLOSURE Consulting* Cook Medical Inc., WL Gore Research
More informationThoracic Aortic Research Center. University of Milan
University of Milan Thoracic Aortic Research Center Update on IRAD Santi Trimarchi, MD, PhD Associate Professor of Vascular Surgery, University of Milan Head, Unit of Vascular Surgery II Director, Thoracic
More informationTEVAR for Chronic dissections: indications for TEVAR, long term results
TEVAR for Chronic dissections: indications for TEVAR, long term results J Sobocinski, R Azzaoui, B Maurel, R Spear, T Martin-Gonzalez, A Hertault, S Haulon Centre de l Aorte, Chirurgie vasculaire, Hôpital
More informationThe natural history of uncomplicated type B dissection, PAU and IMH: the IRAD knowledge. Santi Trimarchi, MD, PhD
IRCCS Policlinico San Donato University of Milan Thoracic Aortic Research Center The natural history of uncomplicated type B dissection, PAU and IMH: the IRAD knowledge Santi Trimarchi, MD, PhD No COI
More informationChallenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
More informationDevelopment of a Branched LSA Endograft & Ascending Aorta Endograft
Development of a Branched LSA Endograft & Ascending Aorta Endograft Frank R. Arko III, MD Sanger Heart & Vascular Institute Carolinas Medical Center Charlotte, North Carolina, USA Disclosures Proximal
More informationI-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical Department National Taiwan University Hospital
Comparisons of Aortic Remodeling and Outcomes after Endovascular Repair of Acute and Chronic Complicated Type B Aortic Dissections I-Hui Wu, M.D. Ph.D. Clinical Assistant Professor Cardiovascular Surgical
More informationPreliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study Mark A Farber, MD Professor of Surgery and Radiology Director, UNC Aortic Network University of North
More informationNeurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA
ISES Online Neurological Complications of Frank J Criado, MD TEVAR Union Memorial-MedStar Health Baltimore, MD USA frank.criado@medstar.net Paraplegia Incidence is 0-4% after surgical Rx of TAAs confined
More informationManagement of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria
Management of Acute Aortic Syndromes M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria I have nothing to disclose. Acute Aortic Syndromes Acute Aortic Dissection Type
More informationUC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures.
An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR Disclosures Royalties and research grant support from Cook Medical, Inc. Jade S. Hiramoto,
More informationPercutaneous Approaches to Aortic Disease in 2018
Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper
More informationAcute Type B dissection. Closure of the infra diaphragmatic tear: how and when?
Acute Type B dissection. Closure of the infra diaphragmatic tear: how and when? Prof. Olgierd Rowiński II Department of Clinical Radiology Medical University of Warsaw Disclosure Speaker name: Olgierd
More informationADSORB trial results: Is it enough to switch the paradigm?
ADSORB trial results: Is it enough to switch the paradigm? Jan Brunkwall, MD, PhD Professor and Chairman Complications to acute type B dissection Mortality Rupture Organ Ischemia Dilatation/Aneurysm Refractory
More informationENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
More informationClinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study
Clinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study Theodoros Kratimenos, MD Consultant, Interventional Radiologist
More informationDissection de type B: l étude Instead et corollaire stratégique
Dissection de type B: l étude Instead et corollaire stratégique Christoph A. Nienaber, MD, FACC University Rostock Heartcenter Med. Clinic I Cardiology christoph.nienaber@med.uni-rostock.de Type B aortic
More informationEndoanchor-assisted TEVAR
Endoanchor-assisted TEVAR May 29, 2015 NCVH2015 Grayson H. Wheatley III, MD Director of Aortic and Endovascular Surgery Associate Professor of Surgery Temple University School of Medicine Disclosures Consultant
More informationIndications for use. Contraindications within the United States
Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions
More informationEndovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui Aortic Center, Lille University Hospital, France Disclosures
More informationOpen fenestration for complicated acute aortic B dissection
Art of Operative Techniques Open fenestration for complicated acute aortic B dissection Santi Trimarchi 1, Sara Segreti 1, Viviana Grassi 1, Chiara Lomazzi 1, Marta Cova 1, Gabriele Piffaretti 2, Vincenzo
More informationAntegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation
Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation Vallabhajosyula, P: Szeto, W; Desai, N; Pulsipher, A;
More informationAortic Center of Excellence at Sentara
Gordon K. Stokes, MD, FACS Eastern Virginia Medical School Sentara Vascular Specialists Norfolk, VA Aortic Center of Excellence at Sentara April 25, 2014 Disclosures I have no disclosures relevant to this
More informationEuropean Experience with a New Thoracic Device. D.Böckler University Hospital Heidelberg Germany
European Experience with a New Thoracic Device D.Böckler University Hospital Heidelberg Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts of interest to report:
More informationDo the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D.
Do the Data Support Endovascular Therapy for Descending Thoracic AD? Woong Chol Kang, M.D. Gil Hospital, Gachon University Incheon, Korea Classification of AD Acute vs. Chronic (2weeks) (IIIa, b) type
More informationTotal endovascular techniques utilization in aortic dissection radical treatment
Total endovascular techniques utilization in aortic dissection radical treatment Chang Shu, MD, PhD Vascular Surgery Center National Center for Cardiovascular Diseases. Fuwai Hospital, CAMS & PUMC Beijing,
More informationSubclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair
Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair Simone Salvati, Luca Bertoglio, Alessandra Fittipaldi, Andrea
More informationTreatment of acute type B aortic dissection: Current status
MEET Cannes, 18. - 21.06.2009 Treatment of acute type B aortic dissection: Current status Christoph A. Nienaber, MD, FACC University of Rostock Department of Internal Medicine, Cardiology christoph.nienaber@med.uni-rostock.de
More informationToward Total Endovascular Therapy of the Aorta. Adam W. Beck, MD. Associate Professor of Surgery Division of Vascular Surgery and Endovascular Therapy
Toward Total Endovascular Therapy of the Aorta Adam W. Beck, MD Associate Professor of Surgery Division of Vascular Surgery and Endovascular Therapy University of Alabama at Birmingham Disclosures Grant
More informationEndovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad).
Endovascular therapy for Ischemic versus Nonischemic complicated acute type B aortic dissection (catbad). AS. Eleshra, MD 1, T. Kölbel, MD, PhD 1, F. Rohlffs, MD 1, N. Tsilimparis, MD, PhD 1,2 Ahmed Eleshra
More informationEndovascular Stent Grafts for Disorders of the Thoracic Aorta
Endovascular Stent Grafts for Disorders of the Thoracic Aorta Policy Number: 7.01.86 Last Review: 9/2018 Origination: 5/2006 Next Review: 9/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC)
More informationObjective assessment of current stent grafts: which graft for which lesion. Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France
Objective assessment of current stent grafts: which graft for which lesion Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France Conflict of interest: none 1 Introduction Different diseases
More informationAggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection
Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria Disclosure Statement Consultant of Jotec, Hechingen,
More informationEarly outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD
Early outcomes of acute retrograde dissection in the aortic arch and the ascending aorta data from IRAD Foeke JH Nauta, MD, PhD Resident Cardiothoracic Surgery, Academic Medical Center, Amsterdam Disclosure
More informationTreatment of complex thoracic cases Focus on the new Gore Active Control TAG device
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device Professor Christoph A. Nienaber The Royal Brompton and Harefield NHS Trust Cardiology and Aortic Centre C.Nienaber@rbht.nhs.uk
More informationArch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience
Arch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience Joost van Herwaarden, MD, PhD University Medical Center, Utrecht Disclosure I have the following potential
More informationOptimal Treatment of Chronic Dissection
Optimal Treatment of Chronic Dissection Chun-Che Shih 施俊哲 MD, Ph.D. Chief, Professor Institute of Clinical Medicine National Yang Ming University Division of Cardiovascular Surgery Taipei Veterans General
More informationChallenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak
Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)
More informationDescription. Section: Surgery Effective Date: October 15, 2016 Subsection: Surgery Original Policy Date: December 7, 2011 Subject:
Last Review Status/Date: September 2016 Page: 1 of 30 Description Thoracic endovascular aneurysm repair (TEVAR) involves the percutaneous placement of a stent graft in the descending thoracic or thoracoabdominal
More informationIs a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified?
Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified? Dittmar Böckler Department of Vascular and Endovascular Surgery University of Heidelberg, Germany Disclosure Speaker
More informationSubject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta
02-33000-29 Original Effective Date: 04/15/03 Reviewed: 07/26/18 Revised: 08/15/18 Subject: Endovascular Stent Grafts for Disorders of the Thoracic Aorta THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,
More informationMechanisms of and treatment strategies for dsine after TEVAR for acute and chronic type B aortic dissection- insights from EuREC.
Mechanisms of and treatment strategies for dsine after TEVAR for acute and chronic type B aortic dissection- insights from EuREC Martin Czerny Content EuREC Contributors dsine Mechanisms Results Summary
More informationINCRAFT system: Update from the Pivotal INSPIRATION Study
INCRAFT system: Update from the Pivotal INSPIRATION Study Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh
More informationMy personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
More informationDevelopment of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection.
Development of Stent Graft Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection. ASAIO J 1993 The New England Journal of Medicine Downloaded from nejm.org
More informationJean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS Arch Pathology: The Endovascular Era is here Disclosures Consultant: Cook Medical, Bolton Medical, Medtronic Inc, Volcano,
More informationHybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm
Hybrid Repair of a Complex Thoracoabdominal Aortic Aneurysm Virendra I. Patel MD MPH Assistant Professor of Surgery Massachusetts General Hospital Division of Vascular and Endovascular Surgery Disclosure
More informationEndovascular Stent Grafts for Disorders of the Thoracic Aorta
Endovascular Stent Grafts for Disorders of the Thoracic Aorta Policy Number: 7.01.86 Last Review: 9/2017 Origination: 5/2006 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC)
More informationReimbursement Guide Zenith Fenestrated AAA Endovascular Graft
MEDICAL Reimbursement Guide Zenith Fenestrated AAA Endovascular Graft Disclaimer: The information provided herein reflects Cook s understanding of the procedure(s) and/or device(s) from sources that may
More informationExperience of endovascular procedures on abdominal and thoracic aorta in CA region
Experience of endovascular procedures on abdominal and thoracic aorta in CA region May 14-15, 2015, Dubai Dr. Viktor Zemlyanskiy National Research Center of Emergency Care Astana, Kazakhstan Region Characteristics
More informationTHORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR
Update on Open and Endovascular Therapeutic Option for Aortic Repair CENTRE CARDIO-TORACIQUE DE MONACO Friday November 7 th, 2014 THORACOABDOMINAL AORTIC ANEURYSMS HYBRID REPAIR Roberto Chiesa Vascular
More informationEndovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
More informationThe role of false lumen intervention to promote remodelling via induced thrombosis the FLIRT concept
The role of false lumen intervention to promote remodelling via induced thrombosis the FLIRT concept Professor Christoph A. Nienaber The Royal Brompton and Harefield NHS Trust Cardiology and Aortic Centre
More informationDurable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
More informationTEVAR FOR! THORACIC AORTIC TRAUMA"
10th HKL Vascular Surgery Conference and Workshop" TEVAR FOR! THORACIC AORTIC TRAUMA" Dr Hanif Hussein" Vascular and General Surgeon" Department of Surgery" Hospital Kuala Lumpur" Source: MIROS! Thoracic
More informationTEVAR for the Ascending Aorta
TEVAR for the Ascending Aorta Himanshu J. Patel MD Joe D. Morris Collegiate Professor Section Head, Adult Cardiac Surgery University of Michigan Frankel Cardiovascular Center Disclosures Himanshu J. Patel
More informationAcute dissections of the descending thoracic aorta (Debakey
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford
More informationTalent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
More informationDISCLOSURES ISOLATED DTA LESION? TYPE B DISSECTIONS TREATMENT OPTIONS
Endovascular Repair of Aortic Arch Pathologies; What is available/possible in the U.S. in 2018? Kaiser Permanente Endovascular Symposium 6/2/18 Sukgu M Han, MD, MS Assistant Professor of Clinical Surgery
More informationAdvances in Treatment of Traumatic Aortic Transection
Advances in Treatment of Traumatic Aortic Transection Himanshu J. Patel MD University of Michigan Medical Center Author Disclosures Consulting fees from WL Gore Inc. There is no disease more conducive
More informationHow to achieve a successful proximal sealing in TEVAR? Pr L Canaud
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud CHU de Montpellier France Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic. Proximal neck
More informationAnimesh Rathore, MD 4/21/17. Penetrating atherosclerotic ulcers of aorta
Animesh Rathore, MD 4/21/17 Penetrating atherosclerotic ulcers of aorta Disclosures No financial disclosures Thank You Dr. Panneton for giving this lecture for me. I am stuck at Norfolk with an emergency
More informationRedo treatment and open conversion after TEVAR
Redo treatment and open conversion after TEVAR Roberto Chiesa Vascular Surgery, Vita-Salute University Scientific Institute San Raffaele Milan, Italy Number of procedures Off-Label indications for TEVAR
More informationI have the following financial relationships to disclose:
Novel Approaches to Endovascular Management of Aortic Aneurysms Rodney A White, MD Medical Director, Vascular Services MemorialCare Heart & Vascular Institute Long Beach Memorial Hospital Long Beach, California
More informationEarly Clinical Results with the Valiant Mona LSA Branch Stent-Graft
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical
More informationAortic stents, types, selection, tricks in deployment.
Aortic stents, types, selection, tricks in deployment. Hamdy Soliman.M.D,FSCAI Consultant of Cardiology&Head of Endovascular Unit National Heart Institute Endovascular Treatment of Thoracic Aortic Aneurysms
More informationProspective Study of the E-liac Stent Graft System in Patients with Common Iliac Artery Aneurysm: 30-Day Results
Prospective Study of the E-liac Stent Graft System in Patients with Common Iliac Artery Aneurysm: 30-Day Results J. Brunkwall MD, Ph.D, FEBVS On behalf of the Pliant study groups E-liac Stent Graft System
More informationThree year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization
Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization Thomas Larzon, MD, PhD Head of Vascular Surgery Dept of Cardiothoracic
More informationGORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER Section I Clinical experience. Section II Worldwide commercial experience
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER 2018 Abstract This annual clinical update provides a review of the ongoing experience with the GORE EXCLUDER AAA Endoprosthesis used in the
More informationTitle. Different arch branched devices are available, is morphology the. main criteria of choice? Ciro Ferrer, MD
Different arch branched devices are available, is morphology the Title main criteria of choice? Ciro Ferrer, MD Vascular Surgery Unit Sapienza University of Rome Disclosure Speaker name: Ciro Ferrer Proctoring/speaking
More informationResidual Dissection and False Lumen Aneurysm After TEVAR
WHAT WOULD YOU DO? Residual Dissection and False Lumen Aneurysm After MODERATOR: MARK FARBER, MD PANEL: YAZAN DUWAYRI, MD; MATTHEW J. EAGLETON, MD; WILLIAM D. JORDAN Jr, MD; TILO KÖLBEL, MD, PhD; AND ERIC
More informationHistory of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
More informationAccess More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
More informationType B Dissection Sub-Categories
Disclosure Nothing to disclose Type B Dissection On Whom to Operate on and When to do it Charles Eichler Professor, Department of Surgery Division of Vascular and Endovascular Surgery University of California
More informationAortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
More informationIntravascular Ultrasound in the Treatment of Complex Aortic Pathologies. Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018
Intravascular Ultrasound in the Treatment of Complex Aortic Pathologies Naixin Kang, M.D. Vascular Surgery Fellow April 26 th, 2018 DISCLOSURES Nothing To Disclose 2 ENDOVASCULAR AORTIC INTERVENTION Improved
More informationTaming The Aorta. David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA
Taming The Aorta David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA Faculty Disclosure Consulting: Endologix, Cook 1 Objectives Review the
More informationPredictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg Disclosure
More informationAbdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke
Abdominal Aortic Aneurysms A Surgeons Perspective Dr. Derek D. Muehrcke Aneurysm Definition The abnormal enlargement or bulging of an artery caused by an injury or weakness in the blood vessel wall A localized
More informationDurability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
More informationNellix Endovascular System: Clinical Outcomes and Device Overview
Nellix Endovascular System: Clinical Outcomes and Device Overview Jeffrey P. Carpenter, MD Professor and Chief, Department of Surgery CAUTION: Investigational device. This product is under clinical investigation
More informationFollow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011
Follow-up of Aortic Dissection: How, How Often, Which Consequences Euro Echo 2011 Susan E. Wiegers, MD, FASE Director of Clinical Echocardiography Hospital of the University of Pennsylvania Disclosure
More informationImproving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
More information